Loading...

Insights

articles

The latest publications from Dr. Lanman and his collegues at Lanman Spine And Neurosurgery. VIEW ALL
May 24,2019

Artificial Disc Replacement: Faster recovery times and fewer complications.

Read More
May 10,2019

How artificial disc replacement keeps golfers in the game.

Read More
April 26,2019

The link between weight and spinal disorders.

Read More

press

The latest publications about Dr. Lanman in print and digital media from around the world. VIEW ALL
May 09,2019

Chief Artificial Disc Replacement Innovator Dr. Todd Lanman Selected as Los Angeles’ Premier Provider of New FDA-Approved Anatomical M6 Cervical Disc Device

Los Angeles spinal neurosurgeon Dr. Todd H. Lanman continues to be at the forefront of spinal artificial disc replacement technology, once again leading the release of a new FDA-approved disc replacement device with the M6-C, a device with the first-ever viscoelastic core, which for the first time will mimic the natural structure and movement of

Read More
beckers-spine-1000x400-e1482957607154
April 26,2019

Dr. Todd Lanman takes on Orthofix M6-C device implants — 3 takeaways

Spinal neurosurgeon Todd Lanman, MD, will begin implanting Orthofix’s FDA-approved M6-C disc replacement device in patients with cervical disc degeneration.   Three takeaways:   1. Dr. Lanman founded Beverly Hills, Calif.-based Lanman Spinal Neurosurgery, which is affiliated with Cedars-Sinai Medical Center and UCLA Medical Center, both in Los Angeles.   2. He will begin implanting the M6-C

Read More
April 26,2019

Chief Artificial Disc Replacement Innovator Dr. Todd Lanman Selected as Los Angeles’ Premier Provider of New FDA-Approved Anatomical M6 Cervical Disc Device

Dr. Lanman to begin implanting M6 device in patients suffering from cervical disc degeneration as soon as June. Los Angeles spinal neurosurgeon Dr. Todd H. Lanman continues to be at the forefront of spinal artificial disc replacement technology, once again leading the release of a new FDA-approved disc replacement device with the M6-C, a device

Read More

studies

Dr. Lanman's publications and research featured in the worlds leading medical journals. VIEW ALL
April 10,2017

Long-term clinical and radiographic outcomes of the Prestige LP artificial cervical disc replacement at 2 levels: results from a prospective randomized controlled clinical trial

OBJECTIVE The aim of this study was to assess long-term clinical safety and effectiveness in patients undergoing anterior cervical surgery using the Prestige LP artificial disc replacement (ADR) prosthesis to treat degenerative cervical spine disease at 2 adjacent levels compared with anterior cervical discectomy and fusion (ACDF).   Read More…

Read More
March 31,2017

Cervical disc arthroplasty with the Prestige LP disc versus anterior cervical discectomy and fusion, at 2 levels: results of a prospective, multicenter randomized controlled clinical trial at 24 months

OBJECTIVE The authors compared the efficacy and safety of arthroplasty using the Prestige LP cervical disc with those of anterior cervical discectomy and fusion (ACDF) for the treatment of degenerative disc disease (DDD) at 2 adjacent levels.   METHODS Patients from 30 investigational sites were randomized to 1 of 2 groups: investigational patients (209) underwent

Read More
July 12,2016

Access strategies for revision or explantation of the Charité lumbar artificial disc replacement

Todd H. Lanman, MD, FAANS, FACS (et al)   Many lumbar disc prostheses are constantly in development. The goal in each is to preserve mobility in patients with degenerative disc disease. In this study, Dr. Lanman and his colleagues examine the advantages and disadvantage of lumbar artificial disc replacement (ADR) compared with anterior interbody fusion

Read More

video channel

A collection of original video content from Dr. Lanman and his team at Lanman Spine and Neurosurgery. VIEW ALL

Meet Dr. Lanman and Hear His Story

WATCH OUR VIDEO

Follow Us | @drtoddlanman